240 related articles for article (PubMed ID: 33207888)
1. The diagnostic and predictive value of fecal calprotectin and capsule endoscopy for small-bowel Crohn's disease: a systematic review and meta-analysis.
Xiang B; Dong Z; Dai C
Rev Esp Enferm Dig; 2021 Mar; 113(3):193-201. PubMed ID: 33207888
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin for the prediction of small-bowel Crohn's disease by capsule endoscopy: a systematic review and meta-analysis.
Kopylov U; Yung DE; Engel T; Avni T; Battat R; Ben-Horin S; Plevris JN; Eliakim R; Koulaouzidis A
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1137-44. PubMed ID: 27415156
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin and C-reactive protein are associated with positive findings in capsule endoscopy in suspected small bowel Crohn's disease.
Egea Valenzuela J; Pereñíguez López A; Pérez Fernández V; Alberca de Las Parras F; Carballo Álvarez F
Rev Esp Enferm Dig; 2016 Jul; 108(7):394-400. PubMed ID: 27312194
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn's Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review.
Jung ES; Lee SP; Kae SH; Kim JH; Kim HS; Jang HJ
Gut Liver; 2021 Sep; 15(5):732-741. PubMed ID: 33361549
[TBL] [Abstract][Full Text] [Related]
5. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI
Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of fecal calprotectin and lactoferrin as predictors of small bowel Crohn's disease in patients undergoing capsule endoscopy.
Bar-Gil Shitrit A; Koslowsky B; Livovsky DM; Shitrit D; Paz K; Adar T; Adler SN; Goldin E
Scand J Gastroenterol; 2017 Mar; 52(3):328-333. PubMed ID: 27841040
[TBL] [Abstract][Full Text] [Related]
7. [The Capsule Endoscopy Crohn's Disease Activity Index, clinical activity and fecal calprotectin level in patients with isolated small intestine lesions].
Timerbulatov MV; Grishina EE; Aitova LR; Senderovich EI; Ziganshin TM
Khirurgiia (Mosk); 2021; (9):63-70. PubMed ID: 34480457
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.
Sipponen T; Haapamäki J; Savilahti E; Alfthan H; Hämäläinen E; Rautiainen H; Koskenpato J; Nuutinen H; Färkkilä M
Scand J Gastroenterol; 2012 Jul; 47(7):778-84. PubMed ID: 22519419
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic accuracy of faecal calprotectin and small bowel capsule endoscopy and their correlation in suspected isolated small bowel Crohn's disease.
Hale MF; Drew K; McAlindon ME; Sidhu R
Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1145-50. PubMed ID: 27384306
[TBL] [Abstract][Full Text] [Related]
10. Fecal Calprotectin as a Selection Tool for Small Bowel Capsule Endoscopy in Suspected Crohn's Disease.
Monteiro S; Barbosa M; Cúrdia Gonçalves T; Boal Carvalho P; Moreira MJ; Rosa B; Cotter J
Inflamm Bowel Dis; 2018 Aug; 24(9):2033-2038. PubMed ID: 29722829
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of fecal calprotectin for the prediction of endoscopic activity in patients with inflammatory bowel disease.
Jusué V; Chaparro M; Gisbert JP
Dig Liver Dis; 2018 Apr; 50(4):353-359. PubMed ID: 29396129
[TBL] [Abstract][Full Text] [Related]
12. Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.
Vázquez Morón JM; Pallarés Manrique H; Machancoses FH; Ramos Lora M; Ruiz Frutos C
Rev Esp Enferm Dig; 2017 Feb; 109(2):130-136. PubMed ID: 28071062
[TBL] [Abstract][Full Text] [Related]
13. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
[TBL] [Abstract][Full Text] [Related]
14. Is fecal calprotectin an accurate marker in the management of Crohn's disease?
Vernia F; Di Ruscio M; Stefanelli G; Viscido A; Frieri G; Latella G
J Gastroenterol Hepatol; 2020 Mar; 35(3):390-400. PubMed ID: 31795013
[TBL] [Abstract][Full Text] [Related]
15. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
[TBL] [Abstract][Full Text] [Related]
16. Serum calprotectin as a biomarker for Crohn's disease.
Meuwis MA; Vernier-Massouille G; Grimaud JC; Bouhnik Y; Laharie D; Piver E; Seidel L; Colombel JF; Louis E;
J Crohns Colitis; 2013 Dec; 7(12):e678-83. PubMed ID: 23845231
[TBL] [Abstract][Full Text] [Related]
17. Elevated Faecal Calprotectin Levels are a Reliable Non-Invasive Screening Tool for Small Bowel Crohn's Disease in Patients Undergoing Capsule Endoscopy.
Yousuf H; Aleem U; Egan R; Maheshwari P; Mohamad J; McNamara D
Dig Dis; 2018; 36(3):202-208. PubMed ID: 29466790
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
19. Fecal calprotectin is a strong predictive marker of relapse in Chinese patients with Crohn's disease: a two-year prospective study.
Ye L; Chen BQ; Wang SD; Shi H; Yang Z; Wang FY
Scand J Gastroenterol; 2017 Oct; 52(10):1113-1119. PubMed ID: 28675068
[TBL] [Abstract][Full Text] [Related]
20. Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn's disease patients.
Foster AJ; Smyth M; Lakhani A; Jung B; Brant RF; Jacobson K
World J Gastroenterol; 2019 Mar; 25(10):1266-1277. PubMed ID: 30886509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
